These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 88543)

  • 21. Hepatocellular dysplasia: immunohistochemical and morphometrical evaluation.
    Pollice L; Ricco R; Russo S; Maiorano E; Pagniello G; Delfino-Pesce V
    Appl Pathol; 1988; 6(2):73-81. PubMed ID: 2455530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical study of the appearance of some markers in liver adjoining hepatocellular carcinoma.
    Cantaboni A; Sironi M; Taccagni GL; Ferrari AM
    Basic Appl Histochem; 1986; 30(2):165-72. PubMed ID: 2427060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
    Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
    J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver cell dysplasia in alpha-1-antitrypsin deficiency.
    Cohen C; Derose PB
    Mod Pathol; 1994 Jan; 7(1):31-6. PubMed ID: 8159650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histocompatibility antigens in patients with hepatocellular carcinoma and their relationship to chronic hepatitis B virus infection in these patients.
    Kew MC; Gear AJ; Baumgarten I; Dusheiko GM; Maier G
    Gastroenterology; 1979 Sep; 77(3):537-9. PubMed ID: 222645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray.
    Wang Y; Wu MC; Sham JS; Tai LS; Fang Y; Wu WQ; Xie D; Guan XY
    J Pathol; 2002 Aug; 197(5):610-6. PubMed ID: 12210080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Localization of HBsAg and HBcAg by peroxidase-labeled antibody].
    Hong SF
    Zhonghua Yi Xue Za Zhi; 1985 Jun; 65(6):352-4. PubMed ID: 2994857
    [No Abstract]   [Full Text] [Related]  

  • 28. [Expression and significance of Pre-S1 and Pre-S2 in human primary hepatic carcinoma (PHC)].
    Wang WL
    Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):83-6. PubMed ID: 1319893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nonspecific tumor markers in hepatocellular carcinoma].
    Stanciu L; Dumitraşcu D; Radu D; Badea R; Petcovici M; Ioniţă A; Szabo P; Pascu O
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(5):443-9. PubMed ID: 2473509
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunocytochemical evaluation of liver fine-needle aspirations.
    Bedrossian CW; Davila RM; Merenda G
    Arch Pathol Lab Med; 1989 Nov; 113(11):1225-30. PubMed ID: 2479356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Identification of hepatitis B antigens in hepatic tissue in various forms of acute hepatitis].
    Sarno EN; Vieira LM; Alvariz FG
    Arq Gastroenterol; 1984; 21(2):68-74. PubMed ID: 6393924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of expression of hepatitis B surface and core antigens (HBsAg, HBcAg) in resected primary and recurrent hepatocellular carcinoma in HBsAg carriers in Taiwan. Correlation with local host immune response.
    Hsu HC; Wu TT; Wu MZ; Wu CY; Chiou TJ; Sheu JC; Lee CS; Chen DS
    Cancer; 1988 Sep; 62(5):915-21. PubMed ID: 2842026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
    Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
    Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B surface antigenemia in patients with hepatocellular carcinoma in relation to clinical course and alpha-fetoprotein.
    Kubo Y; Okuda K; Shimokawa Y; Arishima T; Nagata E
    Gastroenterology; 1977 Jun; 72(6):1213-6. PubMed ID: 67061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver.
    Gerber MA; Thung SN; Shen S; Stromeyer FW; Ishak KG
    Am J Pathol; 1983 Jan; 110(1):70-4. PubMed ID: 6185004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of HBAg in the liver in patients with schistosomiasis complicated by liver carcinoma].
    Li Z
    Zhonghua Yi Xue Za Zhi; 1990 Sep; 70(9):491-3, 34. PubMed ID: 1964849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha fetoprotein and carcinoembryonic antigen producing hepatocellular carcinoma. A case report studied by immunohistochemistry.
    Amano S; Kataoka H; Hazama F; Nakatake M; Maki A
    Acta Pathol Jpn; 1985 Jul; 35(4):969-74. PubMed ID: 2416187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus surface and core antigens in the liver of primary hepatocellular carcinoma cases in Virginia.
    Swenson PD; Escobar MR; Silverman JF
    Acta Biol Acad Sci Hung; 1980; 31(1-3):321-8. PubMed ID: 6261496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA antigen in Chinese patients with hepatocellular carcinomas.
    Chan SH; Simons MJ; Oon CJ
    J Natl Cancer Inst; 1980 Jul; 65(1):21-3. PubMed ID: 6156260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.